Pancreatic Cancer Research

ResearcherUniversity of British ColumbiaNo recent work listed

Maziar Riazy

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-2190-0687; OpenAlex author ID A5046308220. Sources: OpenAlex.

Their work

Papers
2 (first author 1, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
7
Papers, trials and grants by year

2015: 1 paper · 2016: none · 2017: 1 paper

Papers 2

  1. A predictive analysis of the SP120 and 10D7G2 antibodies for human equilibrative nucleoside transporter 1 (hENT1) in pancreatic ductal adenocarcinoma treated w… First author DOI 10.1002/cjp2.75↗
  2. Mismatch repair status may predict response to adjuvant chemotherapy in resectable pancreatic ductal adenocarcinoma. Co-author DOI 10.1038/modpathol.2015.89↗

Closest collaborators

The 7 strongest of 7 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Renata D’Alpino Peixoto · 2 shared papers, 2015–2017 · strength 0.12
  2. Steve E. Kalloger · 2 shared papers, 2015–2017 · strength 0.12
  3. David F. Schaeffer · 2 shared papers, 2015–2017 · strength 0.12
  4. Daniel John Renouf · 2 shared papers, 2015–2017 · strength 0.12
  5. Joanna M. Karasinska · 1 shared paper, 2017 · strength 0.06
  6. Basile Tessier‐Cloutier · 1 shared paper, 2017 · strength 0.06
  7. Hui‐Li Wong · 1 shared paper, 2017 · strength 0.06

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.